이상반응 보고

VAERS ID	2007553
성별	여성
나이	88세
주 코드	FR
제약회사	PFIZER\BIONTECH
로트 번호	SCVD1
예방접종 횟수
접종일	2021-11-26
발병일	2021-11-26
상태	입원 사망

증상

무력증(Asthenia)
고혈압(Hypertension)
실신(Malaise)
연하 곤란(Dysphagia)
SARS-CoV-2 테스트(SARS-CoV-2 test)
심전도(Electrocardiogram)
안면 마비(Facial paralysis)
자기 공명 영상(Magnetic resonance imaging)
섭식 장애(Feeding disorder)
혈액 배양(Blood culture)
배양 소변(Culture urine)
사구체 여과율(Glomerular filtration rate)
실어증(Aphasia)
혈압 측정(Blood pressure measurement)
면제(Immunisation)
혈전증(Thrombosis)
조사(Investigation)
초음파 도플러(Ultrasound Doppler)
미생물학 시험(Microbiology test)
허혈성 뇌졸중(Ischaemic stroke)
경동맥 협착증(Carotid artery stenosis)

이환 중 질병

지병

Medical History/Concurrent Conditions: Aortic stricture; Dyslipidaemia; Gastrooesophageal reflux disease; Hypertension arterial; Osteoporosis; Peripheral arterial occlusive disease

기타 의료

ATENOLOL CHLORTHALIDONE; ASPIRINE; AMLODIPINE; INSPRA; LORAZEPAM; CERIS

이전 예방접종

알레르기

임상 검사

Test Name: blood cultures; Result Unstructured Data: Test Result:sterile; Test Name: blood pressure; Result Unstructured Data: Test Result:180 per 80; Test Date: 20211129; Test Name: blood pressure; Result Unstructured Data: Test Result:more than 220; Test Name: cytobacteriological examination of urine; Result Unstructured Data: Test Result:sterile; Test Name: ECG; Result Unstructured Data: Test Result:no rhythm disorder; Test Name: glomerular filtration rate; Result Unstructured Data: Test Result:84 ml/min; Test Name: GIR; Result Unstructured Data: Test Result:4 score; Test Name: MRI; Result Unstructured Data: Test Result:M1 sylvian thrombus Left; Test Name: Biology; Result Unstructured Data: Test Result:without abnormality; Test Date: 20211126; Test Name: sars-cov-2 test PCR; Test Result: Negative ; Test Date: 20211130; Test Name: sars-cov-2 test PCR; Test Result: Negative ; Test Name: echodoppler of the supra-aortic trunks; Result Unstructured Data: Test Result:left internal carotid stenosis post bulbar; Comments: estimated at 50%.

증상 상세

180/80 hypertension/Persistent hypertension>220; M1 sylvian thrombus Left; left internal carotid stenosis post bulbar estimated at 50%; Oral feeding impossible; malaise; loss of strength on the right; aphasia; swallowing disorder; Immunisation; Ischemic stroke; right facial paralysis; This is a spontaneous report received from a contactable reporter(s) (Physician) from the Regulatory Authority.
Regulatory number: FR-AFSSAPS-NT20215857.
A 88 year-old female patient received bnt162b2 (COMIRNATY), intramuscular, administration date 26Nov2021 (Lot number: SCVD1) at the age of 88 years as dose number unknown (booster), single for covid-19 immunisation.
Relevant medical history included: "Dyslipidaemia" (unspecified if ongoing); "Gastrooesophageal reflux disease" (unspecified if ongoing); "Hypertension arterial" (unspecified if ongoing); "Aortic stricture" (unspecified if ongoing); "Osteoporosis" (unspecified if ongoing); "Peripheral arterial occlusive disease" (unspecified if ongoing).
Concomitant medication(s) included: ATENOLOL CHLORTHALIDONE; ASPIRINE; AMLODIPINE; INSPRA; LORAZEPAM; CERIS.
Vaccination history included: Covid-19 vaccine (dose 2, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (dose 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation.
The following information was reported: IMMUNISATION (death) with onset 26Nov2021, outcome "fatal", described as "Immunisation"; ISCHAEMIC STROKE (death, medically significant) with onset 26Nov2021, outcome "fatal", described as "Ischemic stroke"; FACIAL PARALYSIS (medically significant) with onset 26Nov2021, outcome "unknown", described as "right facial paralysis"; HYPERTENSION (hospitalization, medically significant), outcome "unknown", described as "180/80 hypertension/Persistent hypertension>220"; THROMBOSIS (medically significant), outcome "unknown", described as "M1 sylvian thrombus Left"; CAROTID ARTERY STENOSIS (medically significant), outcome "unknown", described as "left internal carotid stenosis post bulbar estimated at 50%"; FEEDING DISORDER (medically significant), outcome "unknown", described as "Oral feeding impossible"; MALAISE (non-serious) with onset 26Nov2021, outcome "unknown", described as "malaise"; ASTHENIA (non-serious) with onset 26Nov2021, outcome "unknown", described as "loss of strength on the right"; APHASIA (non-serious) with onset 26Nov2021, outcome "unknown", described as "aphasia"; DYSPHAGIA (non-serious) with onset 26Nov2021, outcome "unknown", described as "swallowing disorder".
The patient underwent the following laboratory tests and procedures: blood culture: (unspecified date) sterile; blood pressure measurement: (unspecified date) 180 per 80; (29Nov2021) more than 220; culture urine: (unspecified date) sterile; electrocardiogram: (unspecified date) no rhythm disorder; glomerular filtration rate: (unspecified date) 84 ml/min; investigation: (unspecified date) 4 score; magnetic resonance imaging: (unspecified date) m1 sylvian thrombus left; microbiology test: (unspecified date) without abnormality; sars-cov-2 test: (26Nov2021) negative; (30Nov2021) negative; ultrasound doppler: (unspecified date) left internal carotid stenosis post bulbar, notes: estimated at 50%.
Therapeutic measures were taken as a result of ischaemic stroke, facial paralysis, hypertension, thrombosis, carotid artery stenosis, feeding disorder, malaise, asthenia, aphasia, dysphagia.
The patient date of death was Dec2021.
The reported cause of death was ischaemic stroke.
It was not reported if an autopsy was performed.
The clinical course was reported as follows: died following an ischemic stroke that occurred 10 minutes after vaccination with R1 (booster) of COMIRNATY (context of 180/80 hypertension and carotid stenosis).
Patient living at home, GIR 4 score.
On 26Nov2021, ten minutes after an R1(booster) of COMIRNATY, the patient presents with malaise with right facial paralysis and loss of strength on the right, aphasia and swallowing disorder.
On admission, BP was 180/80.
Complementary examinations: MRI: M1 sylvian thrombus Left.
EDTSA (echodoppler of the supra-aortic trunks) found a left internal carotid stenosis post bulbar estimated at 50%.
ECG: no rhythm disorder.
Biology (Lab test) without abnormality (GFR at 84mL/min).
Covid PCR negative on 26 and 30Nov2021.
Sterile blood cultures and ECBU (cytobacteriological examination of urine).
Thrombolysis was not chosen.
Aspegic IV started.
Evolution: Persistent hypertension (>220 on 29Nov2021) treated with LOXEN IV.
Oral feeding impossible.
Nasogastric tube pulled out several times.
No improvement of the deficits.
On 16Dec2021 in palliative care.
Death of the patient.
No follow-up attempts are possible.
No further information is expected.
; Reported Cause(s) of Death: Ischemic stroke